BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 5151428)

  • 1. [The effect of streptase (streptokinase) and anticoagulants on the functional state of the thrombocytes of myocardial infarct patients].
    Belousov IuB; Liusov VA
    Klin Med (Mosk); 1971 Jul; 49(7):38-43. PubMed ID: 5151428
    [No Abstract]   [Full Text] [Related]  

  • 2. [Venous treatment with streptase in acute myocardial infarct and unstable stenocardia (a new method)].
    Atanasov K; Dzhurdzhev A; Kichukov N; Ivanov I; Mineva Zh
    Vutr Boles; 1987; 26(2):50-4. PubMed ID: 3604198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Short-term fibrinolytic treatment in acute myocardial infarction].
    Breddin K; Ehrly AM; Fechler L; Frick D; König H; Kraft H; Krause H; Krzywanek HJ; Kutschera J; Lösch HW; Ludwig O; Mikat B; Rausch F; Rosenthal P; Sartory S; Voigt G; Wylicil P
    Dtsch Med Wochenschr; 1973 Apr; 98(17):861-73. PubMed ID: 4571884
    [No Abstract]   [Full Text] [Related]  

  • 4. [Use of antithrombotic drugs in internal medicine].
    Vogel G; Huyke R
    Z Gesamte Inn Med; 1979 Jan; 34(1):28-34. PubMed ID: 373276
    [No Abstract]   [Full Text] [Related]  

  • 5. [Study of the action of intensain on platelet adhesiveness in ischemic heart disease].
    Nicolaescu V; Hergot L; Cîmpeanu A
    Med Interna (Bucur); 1972 Nov; 24(11):1335-40. PubMed ID: 4650951
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of myocardial infarct with anticoagulants, thrombolytics, inhibitors of platelet aggregation and beta receptor blockaders].
    Thiele R
    Z Arztl Fortbild (Jena); 1984; 78(5):167-71. PubMed ID: 6202068
    [No Abstract]   [Full Text] [Related]  

  • 7. Single-blind randomised multicentre trial comparing heparin and streptokinase treatment in recent myocardial infarction.
    Amery A; Roeber G; Vermeulen HJ; Verstraete M
    Acta Med Scand Suppl; 1969; 505():1-35. PubMed ID: 4911123
    [No Abstract]   [Full Text] [Related]  

  • 8. [Capillary resistance in patients with myocardial infarct and angina pectoris and the effect on it by anticoagulants and a preparation of Sorbus aucuparia--Vitamin CP].
    Golubenko BG
    Sov Med; 1967 Apr; 30(4):98-101. PubMed ID: 5608586
    [No Abstract]   [Full Text] [Related]  

  • 9. An audit of thrombolytic therapy in a rural hospital.
    Cohen S; Gibb S
    Aust Fam Physician; 1993 Oct; 22(10):1866-8. PubMed ID: 8280016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapeutic fibrinolysis].
    Straub PW
    Schweiz Med Wochenschr; 1973 May; 103(20):753-7. PubMed ID: 4702993
    [No Abstract]   [Full Text] [Related]  

  • 11. [Blood coagulation state and the dynamic function of the thrombocytes in myocardial infarct in the process of heparin therapy].
    Kesler VM
    Zdravookhr Kirg; 1978; (3):8-11. PubMed ID: 27045
    [No Abstract]   [Full Text] [Related]  

  • 12. [Use of streptase in the acute period of myocardial infarct].
    Zaikin MD; Shumbalina LF; Dymkina IM; Odnoralova LP
    Sov Med; 1972 Dec; 35(12):48-51. PubMed ID: 4668335
    [No Abstract]   [Full Text] [Related]  

  • 13. Antiplatelet aggregant agents and thrombolytic compounds in myocardial infarction: current status.
    Wessler S; Sherman LA
    Circulation; 1972 Apr; 45(4):911-8. PubMed ID: 4555190
    [No Abstract]   [Full Text] [Related]  

  • 14. [Studies on the stability of streptokinase and heparin solutions with the addition of carbochromen].
    Leube G; Kuehn JJ
    Arzneimittelforschung; 1971 May; 21(5):691-3. PubMed ID: 5109697
    [No Abstract]   [Full Text] [Related]  

  • 15. [Streptokinase in myocardial infarct].
    Lasierra Cirujeda L; Viladés Juan E; Fernández Clemente JJ; Dulin Verde JJ; Moreno Resina B; Munilla García A; Macho Fernandez A; Fernandez De La Cigoña F
    Rev Clin Esp; 1977 Feb; 144(4):251-7. PubMed ID: 847260
    [No Abstract]   [Full Text] [Related]  

  • 16. Randomized comparison of a novel anticoagulant, vasoflux, and heparin as adjunctive therapy to streptokinase for acute myocardial infarction: results of the VITAL study (Vasoflux International Trial for Acute Myocardial Infarction Lysis).
    Peters RJ; Spickler W; Théroux P; White H; Gibson M; Molhoek PG; Anderson HV; Weitz JI; Hirsh J; Weaver WD
    Am Heart J; 2001 Aug; 142(2):237-43. PubMed ID: 11479461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Acute myocardial infarct? Open the blood vessel involved].
    de Boer MJ; Zijlstra F
    Ned Tijdschr Geneeskd; 1993 Jul; 137(29):1433-7. PubMed ID: 8361552
    [No Abstract]   [Full Text] [Related]  

  • 18. [The thrombolytic therapy of recent myocardial infarctions].
    van de Loo J
    Z Gesamte Inn Med; 1965 Dec; 20(23):724-7. PubMed ID: 5333410
    [No Abstract]   [Full Text] [Related]  

  • 19. [Thrombolytic therapy of acute myocardial infarct].
    De Giorgi E
    Minerva Cardioangiol; 1972 Nov; 20(11):663-6. PubMed ID: 4643520
    [No Abstract]   [Full Text] [Related]  

  • 20. Megadose heparin and streptokinase produce similar TIMI 3 flow at discharge in patients of acute myocardial infarction presenting between 7-12 hours.
    Dwivedi SK; Pramod K; Gupta R; Saran RK; Narain VS; Puri VK
    Indian Heart J; 2000; 52(2):183-6. PubMed ID: 10893895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.